Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyNAPSe: Progesterone in Severe Traumatic Brain Injury
NCT01143064Phase 3Completed
- Sponsor
- BHR Pharmaceuticals
- Start
- Jun 2010
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 21
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Progesterone with Placebo (2 arms). Primary endpoint: Glasgow Outcome Scale at 6 months. Started Jun 2010; status: completed.
02
Drugs
progesterone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01143064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143064.